Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in the USA / NCT03390920
Starting soon Not applicable

Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions

NCT03390920 · tracked via the Priya Life Science USA tracker
Sponsor
R3 Stem Cell
Phase
Not applicable
Started
2022-01-01
Last updated
2021-09-17

Condition(s) studied

OsteoarthritisTendinitisSports InjuryDegenerative Disc DiseaseDegenerative ArthritisLigament InjuryNeuropathyPelvic Pain

Investigational drug(s) / intervention(s)

Umbilical Allograft

Umbilical Allograft: The umbilical allograft is regulated by the FDA and comes from a lab that is FDA registered.

Study summary

The aim of the study is to determine the efficacy of an Amniotic Fluid Tissue Product for pain relief and functional improvements for all types of musculoskeletal conditions. The study is prospective, with outcome measures being obtained at numerous time points after the regenerative procedure.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: 1. Age 18 and over. 2. Ability to attend follow up visits or at least converse on phone or complete email follow up forms. 4\) Competent to understand the study protocol and provide voluntary informed consent. Exclusion Criteria: 1. Active Infection 2. Pregnancy, Lactating 3. Clotting disorder

Primary outcome measure(s)

  • Short Musculoskeletal Function Assessment Questionnaire (SMFA) — Baseline and then Assess Changes Post Intervention at 4 weeks, 3 mths, 6 mths, 9 mths and one year
    The Short Musculoskeletal Function Assessment Questionnaire (SMFA) is designed to measure the functional status of patients with a broad range of musculoskeletal injuries and disorders.

Trial sites (1)

FacilityCityRegionStatus
Advanced Stem Cell Institute Encino California

More R3 Stem Cell trials in the USA

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain Recruiting

Other trials for the same condition

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease Recruiting
Digital Care Programs for Female Pelvic Health Enrolling by invitation
Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD Active, not recruiting
Cemented vs Cementless Persona Keel RCT Active, not recruiting
Sustained Acoustic Medicine for Osteoarthritis Pain Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03390920 on ClinicalTrials.gov ↗ ← All trials in the USA